Prophylactic Treatment of Episodic Cluster Headache with an Angiotensin II Receptor Blocker (Candesartan Cilexetil); a Randomized, Placebo Controlled Parallel Study.
Phase of Trial: Phase II
Latest Information Update: 22 Apr 2013
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Cluster headache
- Focus Therapeutic Use
- 26 Jun 2011 Results presented at the 15th Congress of the International Headache Society.
- 02 Sep 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 02 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History